For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of RxSight Inc (NASDAQ: RXST) was $16.23 for the day, up 0.81% from the previous closing price of $16.10. In other words, the price has increased by $0.81 from its previous closing price. On the day, 0.59 million shares were traded.
Ratios:
Our analysis of RXST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.65 and its Current Ratio is at 12.68. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
On April 15, 2025, Piper Sandler started tracking the stock assigning a Neutral rating and target price of $18.
UBS Downgraded its Buy to Neutral on April 09, 2025, while the target price for the stock was maintained at $16.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 12 ’25 when Fountain Tamara sold 7,000 shares for $25.71 per share. The transaction valued at 180,002 led to the insider holds 24,793 shares of the business.
TAMARA R FOUNTAIN bought 7,000 shares of RXST for $180,002 on Mar 12 ’25. On Jan 22 ’25, another insider, Maniar Shweta, who serves as the Director of the company, sold 3,519 shares for $30.87 each. As a result, the insider received 108,618 and left with 7,383 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 4.45 while its Price-to-Book (P/B) ratio in mrq is 2.36.
Stock Price History:
Over the past 52 weeks, RXST has reached a high of $61.10, while it has fallen to a 52-week low of $12.53. The 50-Day Moving Average of the stock is -5.48%, while the 200-Day Moving Average is calculated to be -54.67%.
Shares Statistics:
A total of 40.59M shares are outstanding, with a floating share count of 38.04M. Insiders hold about 6.40% of the company’s shares, while institutions hold 91.98% stake in the company.
Earnings Estimates
The stock of RxSight Inc (RXST) is currently in the spotlight, with 6.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.05, with high estimates of $0.01 and low estimates of -$0.24.
Analysts are recommending an EPS of between $0.06 and -$0.74 for the fiscal current year, implying an average EPS of -$0.12. EPS for the following year is $0.07, with 6.0 analysts recommending between $0.56 and -$0.9.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 10 analysts. It ranges from a high estimate of $41.6M to a low estimate of $38.8M. As of the current estimate, RxSight Inc’s year-ago sales were $34.89MFor the next quarter, 10 analysts are estimating revenue of $40.54M. There is a high estimate of $41.8M for the next quarter, whereas the lowest estimate is $38.9M.
A total of 11 analysts have provided revenue estimates for RXST’s current fiscal year. The highest revenue estimate was $189.51M, while the lowest revenue estimate was $161.72M, resulting in an average revenue estimate of $167.56M. In the same quarter a year ago, actual revenue was $139.93MBased on 11 analysts’ estimates, the company’s revenue will be $202.61M in the next fiscal year. The high estimate is $240.8M and the low estimate is $185.31M.
